| 1. | Amlexanox-loaded nanoliposomes showing enhanced anti-inflammatory activity in cultured macrophages: A potential formulation for treatment of oral aphthous stomatitis | 319 | 68 |
| 2. | Sustained Delivery of Salbutamol and Beclometasone From Spray-dried Double Emulsions | 227 | |
| 3. | Comparison of the scope of practice of physician associates with that of healthcare professions with prescribing responsibility from point of registration | 213 | 39 |
| 4. | Prodrug to Probe Solution HFA pMDI Formulation and Pulmonary Esterase Activity | 185 | |
| 5. | Fluorescence Lifetime Imaging of Optically Levitated Aerosol: a Technique to Quantitatively Map the Viscosity of Suspended Aerosol Particles | 180 | 63 |
| 6. | An Investigation of the Solubility of Various Compounds in the Hydrofluoroalkane Propellants and Possible Model Liquid Propellants | 177 | |
| 7. | The Use of Sodium Carboxymethylcellulose in the Preparation of Spray-dried Proteins for Pulmonary Drug Delivery | 161 | |
| 8. | Preparation of Dry Powder Dispersions for Non-viral Gene Delivery by Freeze-drying and Spray-drying | 153 | |
| 9. | Enhanced Dispersibility and Deposition of Spray-dried Powders for Pulmonary Gene Therapy | 151 | |
| 10. | The Use of Amino Acids to Enhance the Aerosolisation of Spray-dried Powders for Pulmonary Gene Therapy | 150 | |
| 11. | The Use of Absorption Enhancers to Enhance the Despersibility of Spray-dried Powders for Pulmonary Gene Therapy | 148 | |
| 12. | Amino Acid-modified Spray-dried Powders with Enhanced Aerosolisation Properties for Pulmonary Drug Delivery | 147 | |
| 13. | Carbomer-modified Spray-dried Respirable Powders for Pulmonary Delivery of Salbutamol Sulphate | 147 | |
| 14. | Sustained Delivery by Leucine-modified Chitosan Spray-dried Respirable Powders | 146 | |
| 15. | Rapid Interrogation of the Physical and Chemical Characteristics of Salbutamol Sulphate Aerosol from a Pressurised Metered-dose Inhaler (pMDI) | 145 | |
| 16. | Measurement of the Raman Spectra and Hygroscopicity of Four Pharmaceutical Aerosols as They Travel from Pressurised Metered Dose Inhalers (pMDI) to a Model Lung | 143 | 100 |
| 17. | Novel pMDI Formulations for Pulmonary Delivery of Proteins | 143 | |
| 18. | The Influence of Formulation Components on the Aerosolisation Properties of Spray-dried Powders | 140 | |
| 19. | Further Evidence of Extensive Pulmonary First-pass Ester Hydrolysis After Airways Administration in Rats | 131 | |
| 20. | Influence of Excipients on Spray-dried Powders for Inhalation | 127 | |
| 21. | Chitosan-based Spray-dried Respirable Powders for Sustained Delivery of Terbutaline Sulfate | 126 | |
| 22. | Modified Release of Beclometasone Dipropionate from Chitosan-based Spray-dried Respirable Powders | 123 | |
| 23. | Spray-dried Powders for Pulmonary Drug Delivery | 114 | |